Next, let's look at the medical testimonials, set up as "some specific medical and scientific opinions concerning ZicamTM:"
<<It makes sense to offer protection where it is needed.
Since colds can lead to so many secondary
complications, this product could be of major
significance for persons with chest and ear problems.
This could be a Godsend for asthmatics."
Murray Grossan, M.D.
Ear, Nose and Throat Specialist
Los Angeles, CA>>
Clearly, Dr. Grossan has no first hand experience with Zicam.
<< "I agree that ZicamTM could potentially be a
significant improvement over previous zinc-containing
formulations, thereby representing a valuable addition
to our otherwise very limited armamentarium for
treating colds."
Richard L. Lubman, M.D.
Pulmonary Medicine
Los Angeles, CA>>
He says this based on what? He doesn't say.
<< "The nasal mucosa is an excellent route for drug
delivery without systemic side effects, especially when
treating conditions that originate in the nasal cavity,
such as the common cold."
Fariba Ghodsian, Ph.D.
Drug Delivery Systems Expert
Los Angeles, CA>>
Sure, but this has nothing to do with Zicam.
It's sort of like Gel Tech's press release, which mainly talks up the fact that lots of people get colds. This is the kind of "Big Picture" hype that you often see when someone's trying to run a stock up.
cont.
|
